Skip to main content

Animations

MJFF Publications

761 - 770 of 8399 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • OPEN
    Title: Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/alz.13729
    Citation Count: 5
  • OPEN
    Title: Single-cell spatial transcriptomic and translatomic profiling of dopaminergic neurons in health, aging, and disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2024.113784
    Citation Count: 8
  • RESTRICTED
    Title: Symmetry of synuclein density in autopsied Parkinson’s disease submandibular glands
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2024.137702
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-024-00401-4
    Citation Count: 9
  • OPEN
    Title: Common genetic risk for Parkinson's disease and dysfunction of the endo-lysosomal system
    Journal Name: Philosophical Transactions of the Royal Society B: Biological Sciences
    Publisher: The Royal Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1098/rstb.2022.0517
    Best OA location URL:
    Citation Count: 5
  • OPEN
    Title: Data‐driven disease progression model of Parkinson's disease and effect of sex and genetic variants
    Journal Name: CPT: Pharmacometrics & Systems Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/psp4.13112
    Citation Count: 5
  • OPEN
    Title: Dopamine neuron activity encodes the length of upcoming contralateral movement sequences
    Journal Name: Current Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.cub.2024.01.067
    Citation Count: 6
  • RESTRICTED
    Title: Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers
    Journal Name: Philosophical Transactions of the Royal Society B: Biological Sciences
    Publisher: The Royal Society
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1098/rstb.2022.0387
    Best OA location URL:
    Citation Count: 3
  • OPEN
    Title: In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies
    Journal Name: Nuclear Medicine and Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nucmedbio.2024.108891
    Citation Count: 8
  • OPEN
    Title: Retromer-dependent lysosomal stress in Parkinson's disease
    Journal Name: Philosophical Transactions of the Royal Society B: Biological Sciences
    Publisher: The Royal Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1098/rstb.2022.0376
    Best OA location URL:
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.